Clinical and Biological Implications of TP53 Abnormalities in Relapsed/Refractory Multiple Myeloma: The DEDALO Study

Vittorio Montefusco, Anna Maria Cafro, Gloria Margiotta-Casaluci, Roberto Mina, Francesca Patriarca, Mattia D’Agostino, Anna Benedetta Dalla Palma, Rita Rizzi, Martina di Trani, Paola Bertazzoni, Gaetano Vaudo, Maria Teresa Petrucci, Laura Paris, Angelo Belotti, Katia Mancuso, Concetta Conticello, Carmelo Carlo-Stella, Mario Boccadoro

Open source

DOI: 10.1016/j.clml.2026.05.013
Published: 2026-08
Container: Clinical Lymphoma Myeloma and Leukemia
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clml.2026.05.013,
  title = {Clinical and Biological Implications of TP53 Abnormalities in Relapsed/Refractory Multiple Myeloma: The DEDALO Study},
  author = {Vittorio Montefusco and Anna Maria Cafro and Gloria Margiotta-Casaluci and Roberto Mina and Francesca Patriarca and Mattia D’Agostino and Anna Benedetta Dalla Palma and Rita Rizzi and Martina di Trani and Paola Bertazzoni and Gaetano Vaudo and Maria Teresa Petrucci and Laura Paris and Angelo Belotti and Katia Mancuso and Concetta Conticello and Carmelo Carlo-Stella and Mario Boccadoro},
  year = {2026},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  doi = {10.1016/j.clml.2026.05.013},
  url = {https://doi.org/10.1016/j.clml.2026.05.013}
}

RIS

TY  - JOUR
TI  - Clinical and Biological Implications of TP53 Abnormalities in Relapsed/Refractory Multiple Myeloma: The DEDALO Study
AU  - Vittorio Montefusco
AU  - Anna Maria Cafro
AU  - Gloria Margiotta-Casaluci
AU  - Roberto Mina
AU  - Francesca Patriarca
AU  - Mattia D’Agostino
AU  - Anna Benedetta Dalla Palma
AU  - Rita Rizzi
AU  - Martina di Trani
AU  - Paola Bertazzoni
AU  - Gaetano Vaudo
AU  - Maria Teresa Petrucci
AU  - Laura Paris
AU  - Angelo Belotti
AU  - Katia Mancuso
AU  - Concetta Conticello
AU  - Carmelo Carlo-Stella
AU  - Mario Boccadoro
PY  - 2026
JO  - Clinical Lymphoma Myeloma and Leukemia
DO  - 10.1016/j.clml.2026.05.013
UR  - https://doi.org/10.1016/j.clml.2026.05.013
ER  -

APA

Montefusco, V., Cafro, A. M., Margiotta-Casaluci, G., Mina, R., Patriarca, F., D’Agostino, M., Palma, A. B. D., Rizzi, R., Trani, M. D., Bertazzoni, P., Vaudo, G., Petrucci, M. T., Paris, L., Belotti, A., Mancuso, K., Conticello, C., Carlo-Stella, C., & Boccadoro, M. (2026). Clinical and Biological Implications of TP53 Abnormalities in Relapsed/Refractory Multiple Myeloma: The DEDALO Study. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2026.05.013

Source records

crossref · retrieved 2026-09-27T12:20:10.359Z